Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Molecular Sees Pretax Profit for 1997

Premium

OXFORD, U.K.--Computer-aided molecular design software vendor Oxford Molecular here announced March 31 that after five unprofitable years, in 1997 it achieved an overall pretax profit of £256,000 for the year. CEO Tony Marchington attributed increased sales to successful cheminformatics and bioinformatics businesses where Oxford's Omiga and RS3 products benefitted from strong customer demand. Oxford's June 1997 acquisition of two profitable firms, Genetics Computer Group and MLR Automation, further strengthened performance, Marchington said.

Oxford's sales revenue--more than half of which originated in the US--was £15.6 million for the year, a 60 percent increase over 1996.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.